NPR2–cGMP–PKG axis in CD8+ T cells is activated by inositol requiring enzyme 1 alpha (IRE1α) inhibitors, decreasing expression of aging biomarker KLRG1 and tumor burden [526]. The gene discussed is CD8A; the disease is neoplasm.